Sage Journals: Discover world-class research

1-10 of 14 results for peginterferon beta-1a

Sort by:

Relevance

Select allExport selected citations

Sort by:

Relevance

Open access

Research article

First published 2016

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis

Thomas F Scott, Bernd C Kieseier, Scott D Newsome [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2018

Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study,ATTAIN

Scott D. Newsome, Thomas F. Scott, Douglas L. Arnold [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2015-7

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE

Bernd C Kieseier, Douglas L Arnold, Laura J Balcer [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021

Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study

Til Menge, Karin Rehberg-Weber, Kirsi Taipale [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021

Bioequivalence of intramuscular and subcutaneous peginterferon beta-1a: results of a phase I,open-label crossover study in healthy volunteers

Yuan Zhao, Kun Chen, Nancy Ramia [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021

Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate

Thomas F. Scott, Ray Su, Kuangnan Xiong [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2024-4

Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program

Marco Salvetti, Sibyl Wray, Gereon Nelles [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2017-1

Peginterferon beta-1a reduces disability worsening in relapsing–remitting multiple sclerosis: 2-year results from ADVANCE

Scott D. Newsome, Bernd C. Kieseier, Shifang Liu [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2023

Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme – results from the non-interventional post-authorization safety study PRIMA

Juliane Klehmet, Yvonne Begus-Nahrmann, Kirsi Taipale [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2017-01

Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma,Breast,Renal,and Colon Xenograft Models

Antonio Boccia, Cyrus Virata, Daniel Lindner [...]

Journal of Interferon & Cytokine Research

Search results